Longer pollen season bringing more risk for asthma patients Research shows the hay fever season is growing longer, and one expert says GPs are at the forefront of helping patients reduce complications.
‘Not for sale’: Australia defends PBS against US big pharma GPs welcome plans to make PBS-listed medicines even cheaper, but it comes as US pharma giants take aim at the scheme.
TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.
PBS co-payment freeze rolls out In 2025, the maximum patient cost for all PBS medicines will remain the same as in 2024 instead of increasing with indexation.
Study links childhood asthma to memory difficulties It found patients had a lower ability to remember specific events, but one GP urged caution, warning it may create ‘unnecessary concern’.
In Practice: RACGP seeking new dermatology Chair Nominations are open for a new Specific Interests Dermatology Chair, for RACGP Fellows or members registered with AHPRA as specialist GPs.
‘Visionary’ review suggests quicker approval of new medicines New subsidised medication approvals would be streamlined and access made easier for vulnerable populations, under a new health technology plan.
New National Sustainable Asthma Care Roadmap released Each year, Australian inhalers cause the same greenhouse impact as 350,000 cars, but experts have found a way to help both patients and the climate.
In Practice: Medicines safety resources The RACGP has a new education toolkit and on-demand recordings for GPs in their role of reducing medicine-related harm.
Asthma breakthrough could prevent disease development New research is paving the way for an ‘exciting’ asthma treatment after scientists isolated a molecule crucial to long-term protection.